Founded in August 2015, Hefei Noratech Pharmaceuticals Co., Ltd. is committed to the R&D and production of novel injections such as long-acting, sustained and controlled release, lipidosome and nanoparticle. Its product development aims at being declared both in China and the United States. Its plant design and construction and process equipment selection are planned according to the FDA of the US, GMP of the EU and GMP of China. It’s equipped with production lines of freeze-dried injection and pre-filled injection and terminal sterilization injection.